Join the innovation ecosystem
This programme is aimed at teams/startups developing on the ANGIE platform. The applications may be related to magnetically steered injectable micro/nano robots and localised targeted drug delivery in general, in the context of finding solutions for conditions such as thrombotic stroke, neoplasms, senile dementia and others.
The goal is to validate the startups’ business and technological concepts.
Start phase (Jan-Mar 2024): find a viable business case and create a prototype development plan for a targeted drug delivery intervention.
Final phase (Mar-Jun 2024): evidence of business viability and the solution technological feasibility.
The application window closes on 23/12/2023. Only the top 5 applying teams will be selected.View the curriculum
Benefits for startups
Expert mentoring: ANGIE’s network of professionals with vertical experience in specific domains can boost the startup’s development by bridging technical/managerial knowledge gaps.
Media coverage: as part of the acceleration programme, startups may get frequent exposure on mainstream and specialized media outlets.
Connections: meet with established medtech/pharma corporations, regulatory bodies, civil society organizations and other meaningful ecosystem stakeholders.
Team size of 2 or more
Be incorporated or willing to
Expertise/focus in drug delivery
Aim to develop a commercial solution
December 2023 to June 2024
ANGIE Acceleration programme
Complete this form to participate in the upcoming workshops of the ANGIE Acceleration Programme. See our event calendar for timeline details.